Low Dose Naltrexone (LDN) is a unique, off-label therapy that temporarily blocks opioid receptors to trigger a rebound effect—boosting your body’s natural endorphins and modulating the immune system. At low doses (1.5–4.5mg), LDN has been shown to reduce chronic inflammation, support autoimmune balance, and improve metabolic function. It’s also gaining traction for its role in appetite regulation and fat loss, especially in individuals with underlying inflammation or insulin resistance. LDN helps recalibrate the body—mentally, immunologically, and metabolically.